Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Equity (deficit)

Note 7 - Equity (deficit)
3 Months Ended
Mar. 31, 2014
Note 7 - Equity (deficit)

Note 7 - Equity (Deficit)


Common Stock


In March 2013, the Company issued 40,000,000 shares, at $.02 per share as partial consideration of the business purchase that included certain assets, patents, and other intellectual property and rights related to the development of Camelina sativa as a biofuels feedstock that it acquired.